bbio market cap july 2023

On July 31, 2023, BridgeBio Pharma (BBIO) had a market capitalization of $5.7B, based on 163.31M shares at a price of $35.01.

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
July 31 2023
$35.01
2,535,700
163,308,600
$5,717,434,086.00
July 28 2023
$34.42
2,928,400
163,308,600
$5,621,082,012.00
July 27 2023
$32.13
2,018,400
163,308,600
$5,247,105,318.00
July 26 2023
$32.41
2,089,500
163,308,600
$5,292,831,726.00
July 25 2023
$32.57
2,277,100
163,308,600
$5,318,961,102.00
July 24 2023
$33.24
3,212,000
163,308,600
$5,428,377,864.00
July 21 2023
$34.13
2,801,100
163,308,600
$5,573,722,518.00
July 20 2023
$34.49
4,876,100
163,308,600
$5,632,513,614.00
July 19 2023
$34.46
6,126,500
163,308,600
$5,627,614,356.00
July 18 2023
$32.52
18,191,500
163,308,600
$5,310,795,672.00
July 17 2023
$32.04
47,288,900
163,308,600
$5,232,407,544.00
July 14 2023
$18.22
2,896,200
163,308,600
$2,975,482,692.00
July 13 2023
$17.31
2,705,900
163,308,600
$2,826,871,866.00
July 12 2023
$18.05
2,436,900
163,308,600
$2,947,720,230.00
July 11 2023
$17.81
2,086,200
163,308,600
$2,908,526,166.00
July 10 2023
$17.36
2,047,700
163,308,600
$2,835,037,296.00
July 07 2023
$16.89
1,432,500
163,308,600
$2,758,282,254.00
July 06 2023
$17.00
1,641,300
163,308,600
$2,776,246,200.00
July 05 2023
$17.49
1,960,500
163,308,600
$2,856,267,414.00
July 03 2023
$17.35
875,500
163,308,600
$2,833,404,210.00